Penicillin-binding protein 5 as an inhibitory target of cefozopran in Enterococcus faecalis

Journal of Antimicrobial Chemotherapy

Volumn 37, Issue 3, 1996, Pages 605-609

  Tsuchimori, Noboru ^a   Okonogi, Kenji ^a  

^a TAKEDA PHARMACEUTICAL COMPANY LIMITED   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CARBON 14; CEFMENOXIME; CEFOZOPRAN; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; IMIPENEM; PENICILLIN BINDING PROTEIN; PENICILLIN G;

ANTIMICROBIAL ACTIVITY; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG PROTEIN BINDING; ENTEROCOCCUS FAECALIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; CARRIER PROTEINS; CEPHALORIDINE; CEPHALOSPORINS; ENTEROCOCCUS FAECALIS; HEXOSYLTRANSFERASES; MICROBIAL SENSITIVITY TESTS; MURAMOYLPENTAPEPTIDE CARBOXYPEPTIDASE; PENICILLIN-BINDING PROTEINS; PEPTIDYL TRANSFERASES; PROTEIN BINDING;

EID: 0030004907     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/37.3.605     Document Type: Article

References (10)

1. Chen, H. Y. & Williams, J. D. (1987). Penicillin-binding proteins in Streptococcus faecalis and Streptococcus faecium. Journal of Medical Microbiology 23, 141-7.
2. Etienne, J., Coulet, M., Brun, Y., Blanchon, J.-F., Demoux, F. & Fleurie, F. (1988). Susceptibilities of streptococcal strains associated with infective endocarditis to nine antibiotics. Chemotherapy (Basle) 34, 113-6.
3. Iwahi, T., Okonogi, K., Yamazaki, T., Shiki, S., Kondo, M., Miyake, A. et al. (1992). In vitro and in vivo activities of SCE-2787, a new parenteral cephalosporin with a broad antibacterial spectrum. Antimicrobial Agents and Chemotherapy 36, 1358-66.
4. Miyake, A., Yoshimura, Y., Yamaoka, M., Nishimura, T., Hashimoto, N. & Imada, A. (1992). Studies on condensed-heterocyclic azolium cephalosporins IV. Synthesis and antibacterial activity of 7b-[2-(5-amino-1,2,4-thiadiazol-3-yl)-2(Z)-alkoxyiminoacetamido]-3-(condensed- heterocyclic azolium)methyl cephalosporins including SCE-2787. Journal of Antibiotics 45, 709-20.
5. Moellering, R. C. (1992). Emergence of Enterococcus as a significant pathogen. Clinical Infectious Disease 14, 1173-8.
6. Musher, D. M. (1985). Streptococcus faecalis and other group D streptococci. In Principles and Practice of Infectious Diseases, 2nd edn (Mandell, G. L., Douglas, R. G. & Bennett, J. E., Eds), pp. 1152-5. John Wiley, New York.
7. Nozaki, Y., Imada, A. & Yoneda, M. (1979). SCE-963, a new potent cephalosporin with high affinity for penicillin-binding proteins 1 and 3 of Escherichia coli. Antimicrobial Agents and Chemotherapy 15, 20-7.
8. Tanaka, N., Hirose, T., Mikuma, N. & Kumamoto, Y. (1993). Fundamental and clinical study of cefozopran in urinary tract infections. Chemotherapy (Tokyo) 41, Suppl. 4, 269-77.
9. Williamson, R., Calderwood, S. B., Moellering, R. C. & Tomasz, A. (1983). Studies on the mechanism of intrinsic resistance to β-lactam antibiotics in group D streptococci. Journal of General Microbiology 129, 813-22.
10. Zighelboim-Daum, S. & Moellering, R. C. (1988). Mechanisms and significance of antimicrobial resistance in enterococci. In Antibiotic Inhibition of Bacterial Cell Surface Assembly and Function (Actor, P., Daneo-Moore, L., Higgins, M. L., Salton, M. R. J., Shockman, G. D., Eds), pp. 603-15. American Society for Microbiology, Washington, DC.